Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Big Is The Primary Care POC Diagnostics Market Today And What Is Its Future Size?

The market size for primary care point-of-care diagnostics has seen significant growth in recent times. The market is projected to increase from $16.35 billion in 2024 to $17.38 billion in 2025, achieving a compound annual growth rate (CAGR) of 6.3%. This growth during the historical period can be credited to the rise in chronic disease cases, the shift towards individualized medicine, growing healthcare spending, the burgeoning of supportive regulatory infrastructures and streamlined approval processes, and a heightened focus on early disease detection and preventive approaches.

In the next few years, significant expansion is expected in the primary care poc diagnostics market, with a projected size of $22.88 billion by 2029, grown at a compound annual growth rate of 7.1%. This potential growth during the forecasted period can be associated with various factors such as the rise of infectious disease outbreaks, broadening applications in non-communicable diseases, growing acceptance in home healthcare environments, expansion in precision medicine initiatives, an increase in healthcare infrastructure investments, a growing disease burden, and the escalating awareness regarding early disease diagnosis. Some major trends anticipated within this period include the fusion of artificial intelligence (AI) and machine learning algorithms, advances in molecular diagnostics technologies, the downsizing and mobility of POC diagnostic devices, the incorporation of intelligent devices, and the application of multiplexing and panel testing in POC diagnostics.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15642&type=smp

What External And Internal Drivers Are Influencing The Primary Care POC Diagnostics Market?

The escalating occurrence of infectious diseases is predicted to drive the expansion of the primary care POC diagnostics market. These are maladies triggered by harmful microorganisms such as bacteria, viruses, fungi, or parasites, which can be transmitted directly or indirectly through contact with surfaces, air, water, or vectors like insects that are contaminated. The rise in infectious diseases can be attributed to substandard environmental conditions, urbanization, antimicrobial resistance, and insufficient vaccination coverage. Primary care POC diagnostics play a critical role in combating these diseases by enabling quick detection, prompt treatment, and effective control measures in diverse healthcare environments. For example, in October 2023, a report by the UK Health Security Agency, a UK governmental body handling public health security, stated that HIV diagnoses in England increased by 22%, moving from 3,118 in 2021 to 3,805 in 2022. Furthermore, in November 2023, the World Health Organization (WHO), a UN agency based in Switzerland focusing on global public health, highlighted that approximately 10.6 million instances of tuberculosis (TB) were reported worldwide in 2022, impacting 5.8 million men, 3.5 million women, and 1.3 million children. Consequently, the escalating occurrence of infectious diseases is propelling the growth of the primary care POC diagnostics market.

How Is The Primary Care POC Diagnostics Market Categorized Across Applications And Types?

The primary care poc diagnosticsmarket covered in this report is segmented –

1) By Product: Glucose Monitoring; Cardiometabolic Testing Products; Infectious Disease Testing Products; Coagulation Testing Products; Pregnancy And Fertility Testing Products; Tumor Or Cancer Marker Testing Products; Cholesterol Testing Products; Hematology Testing Products; Drug-Of-Abuse (DOA) Testing Products; Other Products

2) By Prescription: Prescription Based; Over-The-Counter (OTC) Testing

3) By End-Use: Hospitals; Diagnostic Centers; Research Laboratories; Home-Care Settings; Other End-Uses

Subsegments:

1) By Glucose Monitoring: Blood Glucose Meters; Continuous Glucose Monitoring (Cgm) Systems; Test Strips For Glucose Meters; Glucose Control Solutions

2) By Cardiometabolic Testing Products: Blood Pressure Monitors; Lipid Profile Testing Kits; Hemoglobin A1c Testing Kits; Ecg Or Ecg Monitors; Hba1c Point-Of-Care Devices

3) By Infectious Disease Testing Products: Rapid Strep Tests; Influenza (Flu) Testing Kits; Covid-19 Rapid Tests; Hiv Rapid Testing Kits; Hepatitis Testing Kits; Malaria Rapid Diagnostic Tests (Rdts); Other Infectious Disease Tests

4) By Coagulation Testing Products: Prothrombin Time (Pt) Testing Kits; International Normalized Ratio (Inr) Monitors; Activated Partial Thromboplastin Time (Aptt) Testing Kits; Coagulation Control Solutions; Whole Blood Coagulation Monitors

5) By Pregnancy And Fertility Testing Products: Home Pregnancy Tests (Urine-Based); Ovulation Prediction Kits; Pregnancy Test Strips; Fertility Monitoring Devices

6) By Tumor Or Cancer Marker Testing Products: Psa (Prostate-specific Antigen) Testing Kits; Cea (Carcinoembryonic Antigen) Testing Kits; Ca-125 (Ovarian Cancer Marker) Kits; Her2 Testing Kits; Other Tumor Marker Test Kits

7) By Cholesterol Testing Products: Total Cholesterol Testing Kits; Ldl Or Hdl Testing Kits; Triglyceride Testing Kits; Point-Of-Care Lipid Panel Devices

8) By Hematology Testing Products: Hemoglobin Test Kits; Hematocrit Testing Kits; Complete Blood Count (Cbc) Kits; Point-Of-Care Hematology Analyzers; Hemoglobin A1c Testing Devices

9) By Drug-Of-Abuse (Doa) Testing Products: Urine Drug Tests; Oral Fluid Drug Tests; Saliva-Based Drug Tests; Blood-Based Drug Tests; Breath Alcohol Tests

10) By Other Products: Allergy Testing Kits; Urinalysis Test Strips; Vitamin And Mineral Deficiency Testing Kits; Point-Of-Care Liver Function Tests; Kidney Function Testing Products; Blood Gas Testing Devices

Which Emerging Trends Are Reshaping The Primary Care POC Diagnostics Market Landscape?

In order to maximize market revenue, major corporations in the primary care POC diagnostics market are placing their focus on highly advanced technological solutions such as portable point-of-care RT-PCR systems. These portable POC RT-PCR solutions are compact, mobile devices intended to carry out real-time reverse transcription polymerase chain reaction tests outside of the traditional lab environments. For instance, an Indian molecular diagnostic solutions producer, Genes2Me Pvt. Ltd., presented the Rapi-Q Point of Care RT PCR solution for diseases such as HPV and tuberculosis in October 2022. The eight-well block system, known for its user-friendly interface, is capable of providing quicker results in under 45 minutes. The portability and featherweight of the Rapi-Q system makes it a perfect fit for set-ups like hospitals, health clinics, blood banks, research labs, and airports. The Rapi-Q system also shines in terms of sensitivity, accuracy, and performance and can synchronize with over 50 lyophilized, room-temperature disease detection kits for detecting varied diseases.

Who Are The Global Leaders Steering The Primary Care POC Diagnostics Market Forward?

Major companies operating in the primary care POC diagnostics market are Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers AG, Becton, Dickinson And Company, bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Nova Biomedical Corporation, Randox Laboratories Ltd., Ortho Clinical Diagnostics, Nipro Corporation, OraSure Technologies, Meridian Bioscience Inc., DiaSorin SpA, Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, Fujirebio Diagnostics Inc., Immunodiagnostic Systems Holdings PLC, Quotient Limited, AccuBioTech Co. Ltd., bioMedomics Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/primary-care-poc-diagnostics-global-market-report

What Are The Emerging Regional Trends Driving The Primary Care POC Diagnostics Market?

North America was the largest region in the primary care POC diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the primary care POC diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15642&type=smp

Browse Through More Reports Similar to the Global Primary Care POC Diagnostics Market 2025, By The Business Research Company

Point Of Care Diagnostics Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-devices-and-equipment-global-market-report

Transplant Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/transplant-diagnostics-global-market-report

Blood Transfusion Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model